APA (7th ed.) Citation

MG, B., GD, B., TC, G., SK, C., AJ, L., TJ, K., & CA, L. (2010). The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis. Anti-cancer drugs, 21(5), 532. https://doi.org/10.1097/CAD.0b013e328337d485

Chicago Style (17th ed.) Citation

MG, Bingaman, Basu GD, Golding TC, Chong SK, Lassen AJ, Kindt TJ, and Lipinski CA. "The Autophilic Anti-CD20 Antibody DXL625 Displays Enhanced Potency Due to Lipid Raft-dependent Induction of Apoptosis." Anti-cancer Drugs 21, no. 5 (2010): 532. https://doi.org/10.1097/CAD.0b013e328337d485.

MLA (9th ed.) Citation

MG, Bingaman, et al. "The Autophilic Anti-CD20 Antibody DXL625 Displays Enhanced Potency Due to Lipid Raft-dependent Induction of Apoptosis." Anti-cancer Drugs, vol. 21, no. 5, 2010, p. 532, https://doi.org/10.1097/CAD.0b013e328337d485.